TPA
TECH icon

Trivium Point Advisory’s Bio-Techne TECH Stock Holding History

Trivium Point Advisory’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,560
Closed -$541K – 195
2022
Q4 		$541K Buy
6,560
+120
+2% +$9.53K 0.16% 138
2022
Q3 		$498K Buy
6,440
+220
+4% +$19K 0.15% 142
2022
Q2 		$573K Buy
6,220
+560
+10% +$52.5K 0.17% 138
2022
Q1 		$614K Buy
5,660
+600
+12% +$61.9K 0.14% 156
2021
Q4 		$654K Hold
5,060
– – 0.14% 147
2021
Q3 		$618K Buy
5,060
+500
+11% +$60.9K 0.15% 140
2021
Q2 		$513K Buy
4,560
+540
+13% +$56.8K 0.13% 152
2021
Q1 		$384K Buy
4,020
+680
+20% +$62K 0.1% 156
2020
Q4 		$280K Buy
+3,340
New +$242K 0.08% 167

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Trivium Point Advisory's TECH Position: Q1 2023 in Review

Trivium Point Advisory sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 6,560 shares — an estimated $541K sold.

Trivium Point Advisory first reported a position in TECH in Q4 2020 and held it in 9 quarters. The position peaked at $654K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Trivium Point Advisory reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Trivium Point Advisory sold 6,560 Bio-Techne shares in Q1 2023, an estimated $541K.
  • Trivium Point Advisory first reported a position in Bio-Techne in Q4 2020 and held it in 9 quarters.
  • Trivium Point Advisory's Bio-Techne position peaked at $654K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Trivium Point Advisory's 13F filing for Q1 2023, filed 12 Apr 2023.